These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2530767)

  • 21. [A serotoninergic antidepressive, indalpine].
    Rigal J
    Ann Med Psychol (Paris); 1985 Jul; 143(7):664-76. PubMed ID: 3938629
    [No Abstract]   [Full Text] [Related]  

  • 22. The safety profile of paroxetine.
    Boyer WF; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():61-6. PubMed ID: 1531828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine.
    Bengtsson BO; Lundmark J; Wålinder J
    Br J Psychiatry; 1991 Jun; 158():853-5. PubMed ID: 1831396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of liver enzyme inhibition by cimetidine and enzyme induction by phenobarbitone on the pharmacokinetics of paroxetine.
    Greb WH; Buscher G; Dierdorf HD; Köster FE; Wolf D; Mellows G
    Acta Psychiatr Scand Suppl; 1989; 350():95-8. PubMed ID: 2530801
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of paroxetine and maprotiline on mood, perceptual-motor skills, and eye movements in healthy volunteers.
    Deijen JB; Orlebeke JF; Loriaux SM; de Vries J
    Acta Psychiatr Scand Suppl; 1989; 350():41. PubMed ID: 2530785
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiovascular effects of paroxetine.
    Kuhs H; Rudolf GA
    Psychopharmacology (Berl); 1990; 102(3):379-82. PubMed ID: 2147517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mirtazapine: a review of its clinical efficacy and tolerability.
    Szegedi A; Schwertfeger N
    Expert Opin Pharmacother; 2005 Apr; 6(4):631-41. PubMed ID: 15934889
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinical profile of paroxetine: a novel selective serotonin reuptake inhibitor (SSRI).
    J Clin Psychiatry; 1992 Feb; 53 Suppl():1-68. PubMed ID: 1531815
    [No Abstract]   [Full Text] [Related]  

  • 29. Facet theoretic analysis of the Hamilton-D scale.
    Steinmeyer EM; Möller HJ
    J Affect Disord; 1992 May; 25(1):53-61. PubMed ID: 1385599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
    Schlake HP; Kuhs H; Rolf LH; Bosse T; Schuhknecht E; Rudolf GA; Brune GG
    Acta Psychiatr Scand Suppl; 1989; 350():149-51. PubMed ID: 2530775
    [No Abstract]   [Full Text] [Related]  

  • 31. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP; Boyer WF
    Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction to the development of paroxetine, a novel antidepressant.
    Lassen JB
    Acta Psychiatr Scand Suppl; 1989; 350():13. PubMed ID: 2530764
    [No Abstract]   [Full Text] [Related]  

  • 33. Paroxetine: lack of effect on the tyramine pressor response in man.
    Hassan SM; Wainscott G; Turner P
    Acta Psychiatr Scand Suppl; 1989; 350():49. PubMed ID: 2530789
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunological evaluation of paroxetine.
    Henderson DC; Edwards RG; Weston BJ; Dewdney JM
    Acta Psychiatr Scand Suppl; 1989; 350():40. PubMed ID: 2530784
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical overview of serotonin reuptake inhibitors.
    Rickels K; Schweizer E
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxetine: pharmacokinetic and antidepressant effect in the elderly.
    Lundmark J; Scheel Thomsen I; Fjord-Larsen T; Manniche PM; Mengel H; Møller-Nielsen EM; Pauser H; Wålinder J
    Acta Psychiatr Scand Suppl; 1989; 350():76-80. PubMed ID: 2530794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of paroxetine and other antidepressants in combination with alcohol on psychomotor activity related to car driving.
    Hindmarch I; Harrison C
    Acta Psychiatr Scand Suppl; 1989; 350():45. PubMed ID: 2530787
    [No Abstract]   [Full Text] [Related]  

  • 38. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
    Byrne MM
    Acta Psychiatr Scand Suppl; 1989; 350():138-9. PubMed ID: 2530768
    [No Abstract]   [Full Text] [Related]  

  • 39. Paroxetine in the treatment of depression--a randomized comparison with amitriptyline.
    Laursen AL; Mikkelsen PL; Rasmussen S; le Fèvre Honoré P
    Acta Psychiatr Scand; 1985 Mar; 71(3):249-55. PubMed ID: 3157296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of paroxetine in the elderly.
    Bayer AJ; Roberts NA; Allen EA; Horan M; Routledge PA; Swift CG; Byrne MM; Clarkson A; Zussman BD
    Acta Psychiatr Scand Suppl; 1989; 350():85-6. PubMed ID: 2530796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.